Cargando…
Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients
Background: Solid-organ transplant (SOT) recipients are at a high risk of severe COVID-19, and are priority for vaccination. Here, we describe three cases of severe COVID-19 caused by SARS-CoV-2 B.1.1.7 lineage in vaccinated SOT recipients. Methods: Three SOT patients were hospitalized in the Policl...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402384/ https://www.ncbi.nlm.nih.gov/pubmed/34451931 http://dx.doi.org/10.3390/vaccines9080806 |
_version_ | 1783745777104846848 |
---|---|
author | Loconsole, Daniela Stea, Emma Diletta Sallustio, Anna Fontò, Giulia Pronzo, Virginia Simone, Simona Centrone, Francesca Accogli, Marisa Gesualdo, Loreto Chironna, Maria |
author_facet | Loconsole, Daniela Stea, Emma Diletta Sallustio, Anna Fontò, Giulia Pronzo, Virginia Simone, Simona Centrone, Francesca Accogli, Marisa Gesualdo, Loreto Chironna, Maria |
author_sort | Loconsole, Daniela |
collection | PubMed |
description | Background: Solid-organ transplant (SOT) recipients are at a high risk of severe COVID-19, and are priority for vaccination. Here, we describe three cases of severe COVID-19 caused by SARS-CoV-2 B.1.1.7 lineage in vaccinated SOT recipients. Methods: Three SOT patients were hospitalized in the Policlinico Hospital of Bari (southern Italy) and underwent nasopharyngeal swabs for molecular detection of SARS-CoV-2 genes and spike protein mutations by real-time PCR. One sample was subjected to whole-genome sequencing. Results: One patient was a heart transplant recipient and two were kidney transplant recipients. All were hospitalized with severe COVID-19 between March and May 2021. Two patients were fully vaccinated and one had received only one dose of the BNT162b2 mRNA vaccine. All the patients showed a high viral load at diagnosis, and molecular typing revealed the presence of B.1.1.7 lineage SARS-CoV-2. In all three cases, prolonged viral shedding was reported. Conclusions: The three cases pose concern about the role of the B.1.1.7 lineage in severe COVID-19 and about the efficacy of COVID-19 vaccination in immunocompromised patients. Protecting immunocompromised patients from COVID-19 is a challenge. SOT recipients show a suboptimal response to standard vaccination, and thus, an additive booster or a combined vaccination strategy with mRNA, protein/subunit, and vector-based vaccines may be necessary. This population should continue to practice strict COVID-19 precautions post-vaccination, until new strategies for protection are available. |
format | Online Article Text |
id | pubmed-8402384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84023842021-08-29 Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients Loconsole, Daniela Stea, Emma Diletta Sallustio, Anna Fontò, Giulia Pronzo, Virginia Simone, Simona Centrone, Francesca Accogli, Marisa Gesualdo, Loreto Chironna, Maria Vaccines (Basel) Article Background: Solid-organ transplant (SOT) recipients are at a high risk of severe COVID-19, and are priority for vaccination. Here, we describe three cases of severe COVID-19 caused by SARS-CoV-2 B.1.1.7 lineage in vaccinated SOT recipients. Methods: Three SOT patients were hospitalized in the Policlinico Hospital of Bari (southern Italy) and underwent nasopharyngeal swabs for molecular detection of SARS-CoV-2 genes and spike protein mutations by real-time PCR. One sample was subjected to whole-genome sequencing. Results: One patient was a heart transplant recipient and two were kidney transplant recipients. All were hospitalized with severe COVID-19 between March and May 2021. Two patients were fully vaccinated and one had received only one dose of the BNT162b2 mRNA vaccine. All the patients showed a high viral load at diagnosis, and molecular typing revealed the presence of B.1.1.7 lineage SARS-CoV-2. In all three cases, prolonged viral shedding was reported. Conclusions: The three cases pose concern about the role of the B.1.1.7 lineage in severe COVID-19 and about the efficacy of COVID-19 vaccination in immunocompromised patients. Protecting immunocompromised patients from COVID-19 is a challenge. SOT recipients show a suboptimal response to standard vaccination, and thus, an additive booster or a combined vaccination strategy with mRNA, protein/subunit, and vector-based vaccines may be necessary. This population should continue to practice strict COVID-19 precautions post-vaccination, until new strategies for protection are available. MDPI 2021-07-21 /pmc/articles/PMC8402384/ /pubmed/34451931 http://dx.doi.org/10.3390/vaccines9080806 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Loconsole, Daniela Stea, Emma Diletta Sallustio, Anna Fontò, Giulia Pronzo, Virginia Simone, Simona Centrone, Francesca Accogli, Marisa Gesualdo, Loreto Chironna, Maria Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients |
title | Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients |
title_full | Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients |
title_fullStr | Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients |
title_full_unstemmed | Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients |
title_short | Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients |
title_sort | severe covid-19 by sars-cov-2 lineage b.1.1.7 in vaccinated solid-organ transplant recipients: new preventive strategies needed to protect immunocompromised patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402384/ https://www.ncbi.nlm.nih.gov/pubmed/34451931 http://dx.doi.org/10.3390/vaccines9080806 |
work_keys_str_mv | AT loconsoledaniela severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT steaemmadiletta severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT sallustioanna severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT fontogiulia severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT pronzovirginia severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT simonesimona severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT centronefrancesca severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT accoglimarisa severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT gesualdoloreto severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients AT chironnamaria severecovid19bysarscov2lineageb117invaccinatedsolidorgantransplantrecipientsnewpreventivestrategiesneededtoprotectimmunocompromisedpatients |